Medicine has abandoned the antique view that individuals with gigantism are simply unusually tall, healthy specimens. Modern endocrinology and disability jurisprudence treat the condition as a systemic, progressive disease. Chronic growth hormone excess alters human biomechanics, overloading the joints, overworking the cardiac system, and straining metabolic pathways.
Early transsphenoidal resection, radiation, and modern somatostatin analogues can now stop pituitary tumors from expanding. Yet biochemical remission is only half the battle. Surviving gigantism means managing the permanent skeletal alterations and cardiovascular wear caused by pediatric hormone surges. As disability evaluation criteria evolve to reflect this systemic reality, patients finally have access to the legal protections, medical accommodations, and long-term care their physical reality demands.
